MedTrace Logo

Quantitative Lung Cancer Screening

NCT03622528 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-11-27

No results posted yet for this study

Summary

The purpose of this project is to validate quantitative lung structure assessment using an automated analysis software (VIDA), for application to low dose computed tomography (LDCT) acquired for lung cancer screening. Currently the software runs on standard dose CT data. In addition, it is the plan to incorporate algorithms into the software to address assessment of any identified pulmonary lesions.

Conditions

Interventions

RADIATION

Chest CT scan

Standard dose chest CT scan

Sponsors & Collaborators

  • Vida Diagnostics, Inc

    collaborator UNKNOWN

  • Jessica Sieren

    lead OTHER

Principal Investigators

  • Jessica Sieren, PhD · University of Iowa

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2024-10-31
Completion
2024-10-31
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622528 on ClinicalTrials.gov